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Dear Editor,
As the primary author of a comprehensive critical
review of the use of non-human primates (NHPs)
in neuroscience research published in ATLA in
2016,1 I very much welcomed issue 45.2 of the jour-
nal, which contained papers of note that asked
questions of biomedical experiments involving
NHPs.  
One of the main motivations for my 2016 review
was my frustration at the repeated, unsound case
put forth by many of those who advocate for contin-
ued, and greater, invasive neuroscience on our pri-
mate cousins. In my view, this case is multiply and
seriously flawed. It overlooks the opposition of the
public to animal experiments, in particular to NHP
neuroscience; it skews the balance of associated
harms and proposed benefits by understating the
former and overstating the latter; it assumes a
default human relevance without critically ques-
tioning this assumption and without appreciating
the abundant evidence against it; it plays down the
capabilities of non-animal alternatives, seeking
shortcomings and imperfections to defend resis-
tance to them, while ignoring those impacting
monkey research. Its advocates claim that their
field of research underpins various past biomedical
breakthroughs where it does not, as well as assert-
ing that NHP-based basic neuroscience must con-
tinue, ‘just in case’ it generates human-relevant
data that are not obtainable by any other means,
that will lead to human clinical benefit — all with-
out evidence.
Professor Beuter’s ATLA paper2 on the develop-
ment of electrical brain stimulation is particularly
welcome, because, while it makes no detailed argu-
ment against animal neuroscience per se, it is one
of a relatively rare breed of papers written by a
neuroscientist that does none of the above.
Instead, it argues for the adoption and greater use
of alternatives to animal use in one specific area of
neuroscience with a positive, scientific, evidence-
based outlook. Rather than seeking to justify the
status quo of animal use, and to highlight per-
ceived shortcomings of alternatives, as many ani-
mal neuroscience papers do, it does what ethics
demand: the opposite. The author, using her con-
siderable experience of the field, summarises rea-
sons to move on and away from animal use, and
toward a scientifically and ethically superior
approach to furthering the development of electri-
cal brain stimulation treatments — an area which
has been especially controversial with regard to
the role and necessity of animal experiments.3,4
Professor Beuter does address the issue of whether
or not animal experiments have made an essential
contribution to some neuroscience breakthroughs,
though does so briefly, because this is chiefly of
academic interest, rather than having any bearing
on the current need for animal methods. She also
mentions some important inter-species differences
that confound the translation of non-human neuro-
scientific data to humans, and which must be at
the forefront of any serious consideration of the
likelihood that animal-based breakthroughs would
be realised in humans, too. She concentrates, how-
ever, on the benefits of cutting-edge imaging and
computational methods of unprecedented and
ever-increasing power, and how computational and
mathematical modelling will facilitate and drive
forward human-specific neuroscience on micro-
scopic, mesoscopic, and macroscopic scales. She not
only outlines a careful and detailed argument for
their greater use in place of animals, but also dis-
cusses reasons why there is intransigence and
reluctance to change (largely due to institutional,
behavioural, technological and financial lock-in),
and how these obstacles may be overcome. 
In the same issue, I found Robert Combes’s edi-
torial5 on Parkinson’s disease to be fascinating,
with its device of James Parkinson travelling for-
ward two centuries in time to see what progress
had been made. One is bound to agree with the
author that Parkinson would be shocked to appre-
ciate the little return seen over that time from
such monumental — and often misleading —
research efforts, largely focused on animal models,
and that he would therefore be an advocate of the
human, in vitro, and in silico studies that have
underpinned recent, belated, advances in the field. 
Finally, Grimm and Eggel’s Comment6 on striv-
ing for a realistic view of animal research con-
tained much that opponents of it would agree with:
the importance of animal welfare and robust, hon-
est harm–benefit analyses; the failure of some
researchers to meet high scientific standards and
to be realistic in the postulated human benefits of
their work; that animal experiments are licensed
based on confidence rather than scientific rigour,
and so on. These are all issues that would benefit
both animals and humans, given some significant
attention. However, their assertions that good sci-
ence primarily produces good data, with societal
benefit secondary, I feel cannot, and should not, be
applied to animal research. Knowledge acquisition
per se may well be valuable, and speculative
research must occasionally give rise to information
that translates to human benefit. However, when
that comes at huge ethical cost, as it does, for
instance, in the case of NHPs, any knowledge
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gained must be pyrrhic in nature. Furthermore,
good data (with regard to human medicine) can
only be derived from good (human relevant) mod-
els — which, I believe, animals are demonstrably
not, and never can be.
It seems clear that heeding the opinions and rec-
ommendations of experienced neuroscientists such
as Professor Beuter, the well-argued probable
opinion of the time-travelling Parkinson, and
Grimm and Eggel’s demands for high animal wel-
fare and honest and realistic harm–benefit analy-
ses, will be of paramount importance for the
advancement and evolution of experiments involv-
ing NHPs, particularly in neuroscience. This will
benefit animals and humans alike.
Sincerely,
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